Apollo Hospitals, Bangalore, Becomes First in India to Earn Dual AHA Certification for Stroke and Chest Pain Care

IMT News Desk
IMT News Desk
· 3 min read
Apollo Hospitals, Bangalore becomes India’s 1st with dual AHA certifications for Comprehensive Stroke and Chest Pain care, strengthening emergency outcomes

Apollo Hospitals, Bangalore, has become the first hospital in India to receive both the Comprehensive Stroke Center and Comprehensive Chest Pain Center certifications from the American Heart Association® (AHA), marking a major milestone in emergency care for two of the country’s most time-critical conditions. These dual certifications recognise the hospital’s ability to deliver rapid, coordinated and evidence-based care to patients presenting with suspected stroke or acute heart attack, from arrival in the emergency department through diagnosis, intervention and critical care.

Stroke is the fourth leading cause of death and the fifth leading cause of disability in India, while cardiovascular disease accounts for nearly 36% of all deaths among adults aged 30- 69 years. As the burden of these conditions continues to rise, improving hospital preparedness and reducing the time taken to diagnose and treat patients have become critical to survival and recovery. Karnataka is estimated to have around 500,000 people living with stroke, placing considerable pressure on its healthcare system. Apollo Hospitals’ Health of the Nation 2026 report further found that 45% of asymptomatic individuals who underwent coronary calcium scoring already showed evidence of coronary artery calcification, underlining how serious heart disease often develops silently until an emergency occurs.

Against this backdrop, the AHA’s dual certification follows an independent, rigorous evaluation of Apollo Hospitals, Bangalore’s readiness to manage patients with suspected stroke or acute heart attack. The assessment covers the entire emergency pathway from triage and initial clinical evaluation to imaging, interventions in the cath lab or stroke unit, and subsequent intensive care and rehabilitation planning. For both stroke and acute heart attack, every minute can influence survival and long-term recovery, making emergency preparedness as crucial as access to specialised treatment.

D.P. Suresh, M.D., FAHA, Incoming Chair of the American Heart Association’s International Committee, said, “For people experiencing stroke or an acute heart attack, timely diagnosis and coordinated treatment can significantly influence recovery. The American Heart Association’s certification programmes recognise hospitals that demonstrate consistent adherence to internationally accepted standards across the continuum of emergency care. Apollo Hospitals, Bangalore, has successfully met the rigorous requirements for both Comprehensive Stroke Center and Comprehensive Chest Pain Center certification.”

Commenting on the milestone, Dr. A.N. Venkatesh, Senior Consultant, Head and Regional Director, Emergency Departments, Apollo Hospitals, Karnataka, said, “When someone arrives with symptoms of a stroke or heart attack, every clinical decision must be made quickly and in a coordinated sequence. That demands experienced teams, clearly defined treatment pathways and seamless collaboration across specialties. This milestone reflects years of strengthening our emergency response processes so that patients receive the right intervention at the earliest possible opportunity.”

The Comprehensive Stroke Center certification recognises hospitals equipped to manage complex stroke cases through advanced neuroimaging, specialised neurological expertise, emergency interventions such as thrombolysis and thrombectomy, and continuous monitoring in dedicated stroke units. The Comprehensive Chest Pain Center certification acknowledges hospitals that can rapidly identify and treat acute coronary syndromes, including ST-elevation myocardial infarction (STEMI), where restoring blood flow at the earliest is critical to limiting heart muscle damage and improving survival.

Akshay Oleti, CEO, Apollo Hospitals, Karnataka Region, added, “Clinical excellence today extends beyond medical expertise to the strength of the systems that support patient care. Benchmarking against internationally recognised standards encourages continuous improvement, greater consistency in care delivery and stronger organisational readiness during medical emergencies. This achievement reinforces our focus on building resilient care models that can respond effectively when every minute matters.”

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk